Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Glycosylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106350565A details enzymatic production of Ginsenoside Rh2. Discover cost-effective, scalable supply chain solutions for high-purity pharmaceutical intermediates.
Patent CN108948105A details a novel five-step chemical synthesis for high-purity GAMG. This process offers significant supply chain stability and cost reduction advantages.
Novel synthetic route for apigenin-7-O-glucoside-4'-O-rhamnoside intermediates. Overcomes extraction limits with high purity, scalable process for API manufacturing.
Patent CN101712668B details a scalable synthetic route for apigenin glycosides, offering high purity and yield compared to plant extraction for reliable supply.
Novel silanization route for Decitabine intermediates offering high purity and industrial scalability without column chromatography.
Patent CN115851694A details a novel immobilized enzyme method for synthesizing 2'-fluoro-deoxyribonucleosides, offering superior stability, reusability, and cost-effective manufacturing for antiviral intermediates.
Patent CN114891049A reveals a stable glycosylation method enabling rapid oligosaccharide synthesis with high yields and simplified purification for reliable pharmaceutical intermediates supplier.
Patent CN102040636A details a novel beta-arbutin synthesis route utilizing alpha-glucose pentaacetate byproducts for significant cost reduction and supply chain stability.
Novel Au(I)-catalyzed glycosylation for high-purity Etoposide. Enhanced selectivity and scalable manufacturing for global pharmaceutical supply chains.
Novel patent CN103626815B details mild glycosylation for spinosyn derivatives. Offers cost reduction in agrochemical manufacturing and high-purity outcomes.
Patent CN101821278A reveals improved decitabine synthesis. Enhanced isomer ratio and yield offer supply chain stability for pharmaceutical intermediates.
Patent CN103539827B details high-yield thiooligosaccharide synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN103374050A reveals a cost-effective synthetic route for Scutellarin using KI/KBr catalysis, eliminating toxic heavy metals and ensuring high-purity supply.
Novel Pummerer reaction method for sulfur-containing aryl carbon glycosides. Mild conditions, high yield, suitable for API intermediate manufacturing.
Novel stable glycosylation donor technology enabling mild conditions and orthogonal protection for high-purity pharmaceutical intermediates manufacturing.
Patent CN101293889B details a novel glycosylation method for artemisinin. Enhance solubility and reduce toxicity with our scalable pharmaceutical intermediate manufacturing.
Novel three-step synthesis improves purity and yield for pharmaceutical intermediates. Reduces cost and enhances supply chain reliability for global buyers.
Novel N2-glycosyl triazole synthesis offers high yield and alpha-glucosidase inhibition for diabetes drug development and supply chain optimization.
Patent CN111100172B reveals a mild Lewis acid catalyzed route for high-purity capecitabine intermediates, offering significant cost and supply chain advantages.
Patent CN106589015A reveals optimized Tribenoside synthesis reducing waste and improving purity. Enables cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.